SCHEMBL2328548

SCHEMBL2328548

COC(=O)[C@H](CCS(=O)(=O)O)NC(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
ALDH1A1 P00352 2/20 0.49
GAA P10253 2/20 0.49
RAB9A P51151 2/20 0.49
LMNA P02545 2/20 0.48
GLA P06280 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KMT2A Q03164 1/20 0.47
TAS1R3 Q7RTX0 5/20 0.46
TAS1R1 Q7RTX1 5/20 0.46
CYP26A1 O43174 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NPC1 O15118 1/20 0.45
PRSS1 P07477 1/20 0.44
CTSG P08311 1/20 0.44
CTRB1 P17538 1/20 0.44
CMA1 P23946 1/20 0.44
CTSL P07711 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2327265 0.89 CYP26A1 (0.47) CA2GAARAB9ALMNAKMT2A
SCHEMBL2327345 0.88 CYP26A1 (0.50) CA1CA2GAARAB9ALMNA
SCHEMBL2323463 0.86 BCHE (0.47) CA1CA2ALDH1A1GAARAB9A
SCHEMBL27822898 0.86 GAA (0.51) CA1CA2ALDH1A1GAARAB9A
SCHEMBL2330340 0.86 GAA (0.51) CA1CA2ALDH1A1GAARAB9A
SCHEMBL712639 0.85 TAS1R3 (0.60) ALDH1A1GAARAB9ALMNAGLA
SCHEMBL2327505 0.85 CA2 (0.52) CA1CA2TDP1
SCHEMBL714905 0.85 TAS1R3 (0.60) ALDH1A1GAARAB9ALMNAGLA
SCHEMBL8235468 0.84 CA1 (0.56) CA1CA2ALDH1A1GAARAB9A
SCHEMBL2324932 0.83 CLPP (0.48) ALDH1A1GAAKMT2ATAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356979-B1 ANTI-WRINKLE AGENTS POLA CHEM IND INC (JP) 2017-10-25 EP disclosed
EP-3173063-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2017-05-31 EP disclosed
US-8835498-B2 Anti-wrinkle agents POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-16 US disclosed
US-20110245343-A1 ANTI-WRINKLE AGENTS POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
EP-2356979-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2011-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245343-A1 ANTI-WRINKLE AGENTS GLA, H1-4, H1-3 CA1 4797/4885CA2 2926/4885ALDH1A1 2655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.